Within the current translational subgroup analysis of AIO-PK0104 we thus tried to exploratively analyze if the EGFR pathway ‘downstream’ mediators pERK and pAKT could serve as biomarkers in advanced pancreatic cancer. Here, EIF2AK3 is linked to pancreatic neoplasm.